Several studies reported that in patients with high-grade ovarian serous carcinoma this response is dysregulated and low levels of glutathione peroxidase 3 were recorded in patients with metastatic or relapsed ovarian cancer [44,45]. This evidence concerns the gene GPX3 and ovarian cancer.